“A new method of delivering medication for opioid addicts gained approval from a Food and Drug Administration advisory panel this week. It’s a matchstick-like insert designed to slip under the skin and release a drug over a period of months. Some physicians say the implant will be a useful addition to the currently short lineup of medication-assisted treatment options.
The rod is called Probuphine, developed by the companies Braeburn Pharmaceuticals and Titan Pharmaceuticals. It contains a medication called buprenorphine which the FDA approved for opioid addiction in 2002 and is currently widely in use. The FDA typically follows the advice of its advisory panels on approvals.”
See related article: FDA Advisers: Approve Implant for Opioid Addiction available at: http://www.webmd.com/mental-health/addiction/news/20160113/opioid-addiction-implant
See related article: Will FDA panel’s second recommendation of approval for implant to treat opioid addiction be enough? available at: http://www.fiercedrugdelivery.com/story/will-fda-panels-second-recommendation-approval-implant-treat-opioid-addicti/2016-01-19
Source: NPR.org – January 15, 2016